New depression pill shows promise in early trial
Symptom relief
Completed
This study tested an experimental oral drug, GM-1020, in 46 adults with major depressive disorder. The goal was to check safety and see if it can quickly improve mood. Researchers measured side effects and depression scores over 24 hours.
Phase: PHASE2 • Sponsor: Gilgamesh Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC